Citi upgraded Charles River Laboratories (NYSE:CRL) and LabCorp (NYSE:LH) while downgrading Quest Diagnostics (NYSE:DGX), ...
WILMINGTON, Mass. (AP) — WILMINGTON, Mass. (AP) — Charles River Laboratories International Inc. (CRL) on Wednesday reported a loss of $215.7 million in its fourth quarter. The Wilmington ...
Charles River Labs previously disclosed that in 2023 it procured between 30% to 50% of non-human primates globally sourced for use in its discovery and safety assessment segment from Cambodia.
Led by Vision Opportunity Master Fund, the round saw participation from existing investors like Charles River Ventures, Khosla Ventures, Jesselson Capital Corporation and ZG Ventures. iSkoot will use ...
Lab services company Charles River Laboratories (NYSE:CRL) reported Q4 CY2024 results exceeding the market’s revenue expectations , but sales fell by 1.1% year on year to $1.00 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results